Nevirapine Shortage Update: What Patients Need to Know in 2026

If you or a family member takes nevirapine for HIV treatment, it's natural to worry about supply disruptions. HIV medications require continuous adherence — missing even a few doses can allow the virus to replicate. This article covers the current 2026 availability status of nevirapine, the history of supply concerns, and what patients can do to protect themselves.

Current Nevirapine Availability Status (2026)

As of 2026, nevirapine is not listed on the FDA drug shortage database. The U.S. market has a healthy supply of nevirapine generic tablets in the 200 mg immediate-release formulation, supported by multiple manufacturers. The 400 mg extended-release tablet is also available generically. The oral suspension (10 mg/mL) is less widely distributed but not in formal shortage.

However, individual pharmacies — particularly smaller retail locations — may not routinely stock nevirapine. It is a specialty medication with a narrower patient base than common generics, so local availability can be inconsistent.

The Brand-Name Discontinuation: What Happened to Viramune?

The original brand-name Viramune and Viramune XR, made by Boehringer Ingelheim, have been discontinued. This was a business decision by the manufacturer — not a safety recall or FDA action. The discontinuation of the brand created some confusion for patients who suddenly saw different packaging and pill appearances when their pharmacy switched them to the generic.

The important thing to know: the generic nevirapine is FDA-approved, therapeutically equivalent to the brand, and produced by multiple reputable manufacturers. A different-looking pill is not a sign of a problem — it's simply a different manufacturer's version of the same molecule.

Why Nevirapine Can Still Be Hard to Find Despite No Official Shortage

There is a difference between a national supply shortage and local pharmacy availability. Nevirapine isn't manufactured in scarce quantities — the issue is distribution and demand. Because nevirapine is no longer a preferred first-line treatment in major U.S. guidelines, fewer new patients are started on it. This lower demand means some pharmacies don't keep it in regular stock.

At the same time, thousands of existing patients — particularly those who have been on nevirapine for years and are doing well — remain on the medication. These patients face a situation where their medication is readily available at the national level but not always on the shelf at their local pharmacy.

Global Shortage Context: What About Low- and Middle-Income Countries?

Globally, nevirapine remains critically important. In many low- and middle-income countries, nevirapine is still a key HIV treatment and prevention medication because of its low cost and availability. Supply disruptions in global health programs — driven by manufacturing issues, funding gaps, or logistics — can have serious consequences for populations in Africa, Asia, and Latin America. If you follow HIV treatment news internationally, you may see shortage reports that do not apply to the U.S. market.

38,912+ patients found their medications in stock

38K+

Find Nevirapine In Stock Today →

How to Protect Yourself From Supply Disruptions

Even without a formal shortage, smart patients on HIV therapy plan ahead. Here's what you can do:

Ask for 90-day supplies. Most insurance plans allow 90-day fills, especially via mail order. This gives you a larger buffer if local supply fluctuates.

Use a specialty pharmacy. Specialty pharmacies maintain larger inventories of HIV medications and are far less likely to run out than retail pharmacies.

Refill early. Don't wait until your last day of medication. Most insurance plans allow early refills with 7–10 days remaining.

Know your alternatives. Talk to your provider now — before a supply emergency — about what NNRTI or other drug class could be an option if nevirapine becomes unavailable.

Use medfinder. If your pharmacy is out, medfinder will call pharmacies in your area to find which ones have nevirapine in stock.

When to Contact Your HIV Provider About Supply Issues

Contact your HIV care provider immediately if you are unable to locate your nevirapine within 2–3 days before you run out. Your provider may be able to authorize a short emergency supply, recommend a temporary bridge medication, or expedite a transfer to a specialty pharmacy. Do not simply stop taking your medication — reach out for help first.

See also: alternatives to nevirapine if you can't fill your prescription for a full guide to NNRTI alternatives.